Report overview
The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn?s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.
This report contains market size and forecasts of Prescription Gastrointestinal Drugs in global, including the following market information:
Global Prescription Gastrointestinal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prescription Gastrointestinal Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prescription Gastrointestinal Drugs companies in 2021 (%)
The global Prescription Gastrointestinal Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prescription Gastrointestinal Drugs include AstraZeneca, Axcan Pharmaceuticals, Eisai, GlaxoSmithKline, Merck and Salix Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prescription Gastrointestinal Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Gastrointestinal Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Gastrointestinal Drugs Market Segment Percentages, by Type, 2021 (%)
Oral
Topical
Global Prescription Gastrointestinal Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Gastrointestinal Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Prescription Gastrointestinal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prescription Gastrointestinal Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Gastrointestinal Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prescription Gastrointestinal Drugs revenues share in global market, 2021 (%)
Key companies Prescription Gastrointestinal Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prescription Gastrointestinal Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Axcan Pharmaceuticals
Eisai
GlaxoSmithKline
Merck
Salix Pharmaceuticals
